TERNS PHARMACEUTICALS INC. - COMMON STOCK

Terns Reports First Quarter 2021 Financial Results and Provides Corporate Update

13 مايو 2021 15:05:03 بحسب Nasdaq GlobeNewswire

Terns to Present at the 19th Annual Virtual Needham HealthCare Conference

07 أبريل 2021 06:05:00 بحسب Nasdaq GlobeNewswire

Terns Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

30 مارس 2021 15:05:01 بحسب Nasdaq GlobeNewswire

Terns Announces Initiation of Dosing in Phase 1 Clinical Trial of TERN-501, its THR-Beta Agonist in Development for the Treatment of NASH

22 مارس 2021 06:35:00 بحسب Nasdaq GlobeNewswire

Terns to Present on VAP-1 and FXR at NASH-TAG Conference 2021

08 مارس 2021 06:00:00 بحسب Nasdaq GlobeNewswire

Terns to Present at the Cowen 41st Annual Health Care Conference

23 فبراير 2021 15:35:00 بحسب Nasdaq GlobeNewswire